Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols

BMC Oral Health

Volumn 12, Issue 1, 2012, Pages

  Panghal, Manju ^a   Kaushal, Vivek ^b   Kadayan, Sangeeta ^a   Yadav, Jaya P ^a  

^a MAHARSHI DAYANAND UNIVERSITY   (India)

^b Regional Cancer Institute Pt BDS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; ASPERGILLOSIS; BACTEREMIA; CHEMORADIOTHERAPY; COHORT ANALYSIS; ESCHERICHIA COLI INFECTION; FEMALE; FUNGEMIA; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; LEUKOCYTE COUNT; MALE; MICROBIOLOGY; MIDDLE AGED; MOUTH DISEASE; MOUTH TUMOR; NEUTROPHIL; OPPORTUNISTIC INFECTION; PATHOLOGY; PROSPECTIVE STUDY; PROTEUS INFECTION; PSEUDOMONAS INFECTION; RADIATION DOSE; RISK FACTOR; SQUAMOUS CELL CARCINOMA; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; THRUSH;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPERGILLOSIS; BACTEREMIA; CANDIDIASIS, ORAL; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; COHORT STUDIES; ESCHERICHIA COLI INFECTIONS; FEMALE; FUNGEMIA; HUMANS; KLEBSIELLA INFECTIONS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MOUTH DISEASES; MOUTH NEOPLASMS; NEUTROPHILS; OPPORTUNISTIC INFECTIONS; PROSPECTIVE STUDIES; PROTEUS INFECTIONS; PSEUDOMONAS INFECTIONS; RADIOTHERAPY DOSAGE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84869102952     PISSN: None     EISSN: 14726831     Source Type: Journal    
DOI: 10.1186/1472-6831-12-22     Document Type: Article

References (67)

1. Chatzinikalaou I, Abi-Said D, Bodey GP, Rolston KVI, Tarrand JJ, Samonis G. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer Retrospective Analysis of 245 Episodes. Archieve Intern Med 2000, 160:501-509.
2. Rolston KV. The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments. Clin Infect Dis 2004, 39(Suppl 1):44-48.
3. Kanas RJ, Jensen JL, DeBoom GW. Painful oral mucosal ulcers in a patient with small cell carcinoma of the lung. J Am Dent Assoc 1987, 115(1):75-76.
4. Redding SW, Zellars RC, Kirkpatrick WR, McAtee RK, Caceres MA, Fothergill AW, LopezRibot JL, Bailey CW, Rinaldi MG, Patterson TF. Epidemiology of Oropharyngeal Candida Colonization and Infection in Patients Receiving Radiation for Head and Neck Cancer. J Clin Microbiol 1999, 37(12):3896-3900. 85839, 10565903.
5. Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA. Bacterial diversity in human subgingival plaque. J Bacteriol 2001, 183:3770-3783. 10.1128/JB.183.12.3770-3783.2001, 95255, 11371542.
6. Trotti A, Bellm LA, Epstein JB. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003, 66:253-262. 10.1016/S0167-8140(02)00404-8, 12742264.
7. Sonis ST, Elting LS, Keefe D. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004, 100:1995-2025. 10.1002/cncr.20162, 15108222.
8. Vera-Llonch M, Oster G, Hagiwara M. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 2006, 106:329-336. 10.1002/cncr.21622, 16342066.
9. Nagy K, Urban E, Fazekas O. Controlled study of lactoperoxidase gel on oral flora and saliva in irradiated patients with oral cancer. J Craniofac Surg 2007, 18:1157-1164. 10.1097/scs.0b013e3180de6311, 17912104.
10. Lalla RV, Latortue MC, Hong CH, Ariyawardana A, Amato D, Palumbo S, Fisher DJ, Martof A, Nicolatou GC, Patton LL, Elting LS, Spijkervet FK, Brennan MT. A systematic review of oral fungal infections in patients receiving cancer therapy. Support Care Cancer 2010, 18(8):985-992. 10.1007/s00520-010-0892-z, 2914797, 20449755.
11. Raber-Durlacher JE, Weijl NI, Abu Saris M, de Koning B, Zwinderman AH, Osanto S. Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases. Support Care Cancer 2000, 8:366-371. 10.1007/s005200050004, 10975685.
12. Raber-Durlacher JE, Barasch A, Peterson DE, Lalla RV, Schubert MM, Fibbe WE. Oral complications and management considerations in patients treated with high-dose chemotherapy. Support Cancer Therapy 2004, 1:219-229.
13. Silverman SJ, Luangjarmekorn L, Greenspan D. Occurrence of oral Candida in irradiated head and neck cancer patients. J Oral Med 1984, 39:194-196.
14. Leung WK, Dassanayake RS, Yau JYY, Jin LJ, Yam WC, Samaranayake LP. Oral colonization, phenotypic, and genotypic profiles of Candida species in irradiated, dentate, xerostomic, nasopharyngeal carcinoma survivors. J Clin Microbiol 2000, 38:2219-2226. 86768, 10834980.
15. Al-Abeid HM, Abu-Elteen KH, Elkarmi AZ, Hamad MA. Isolation and Characterization of Candidaa Spp. In Jordanian cancer patients: Prevalence, Pthogenic Determinants, and Antifungal Sensitivity. Jpn J Infect Dis 2004, 57:279-284.
16. Jham BC, Freire AR. Oral complications of radiotherapy in the head and neck. Revista Brasileira de Otorrinolaringologia 2006, 72(5):704-708. 10.1590/S0034-72992006000500019, 17221065.
17. Jham BC, França EC, Oliveira RR, Santos VR, Kowalski LP. Silva Aa, Freire AR: Candida oral colonization and infection in Brazilian patients undergoing head and neck radiotherapy: a pilot study. Oral Surgery Oral Medicine Oral Pathology Oral Radiology Endodontology 2007, 103:355-358.
18. Epstein JB, Freilich MM, Le ND. Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck. Oral Surg Oral Med Oral Pathol 1993, 76:169-174. 10.1016/0030-4220(93)90199-E, 8361726.
19. Ramirez-Amador V, Silverman S, Mayer P, Tyler M, Quivey J. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg Oral Med Oral Pathol Radiol Endod 1997, 84:149-153.
20. Ueta E, Osaki T, Yoneda K, Yamamoto T. Prevalence of diabetes mellitus in odontogenic infections and oral candidosis. J Oral Pathol Med 1993, 22:168-174. 10.1111/j.1600-0714.1993.tb01051.x, 8391079.
21. Safdar A, Armstrong D. Infectious morbidity in critically ill patients with cancer. Crit Care Clin 2001, 17:531-570. 10.1016/S0749-0704(05)70198-6, 11525048.
22. Velasco E, Santos Thuler LC, Martins CA, Dias LM, Goncalves VM. Nosocomial infections in an oncology intensive care unit. Am J Infect Control 1997, 26:458-462.
23. Simon A, Ammann RA, Bode U, Fleischhack G, Wenchel HM, Schwamborn D, Gravou C, Schlegel P, Rutkowski S, Dannenberg C, Korholz D, Laws HJ, Kramer MH. Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis 2008, 8:70. 10.1186/1471-2334-8-70, 2408583, 18500998.
24. Bryan CS, Hornung CA, Reynolds KL, Brenner ER. Endemic bacteraemia in Columbia, South Carolina. Am J Epidemiol 1986, 123:113-127.
25. Weinstein MP, Towns ML, Quartey SM. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clinical Infectious Disease 1997, 24:584-602.
26. Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998, SENTRY Participants Group. Clin Infect Dis 2000, 30:454-460. 10.1086/313710, 10722427.
27. Simon A, Fleischhack G, Hasan C, Bode U, Engelhart S, Kramer MH. Surveillance for nosocomial and central line related infections among pediatric hematology-oncology patients. Infect Control Hosp Epidemiol 2000, 21:592-596. 10.1086/501809, 11001263.
28. Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. Lancet Oncol 2009, 10:589-597. 10.1016/S1470-2045(09)70069-5, 19482247.
29. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988, 16(3):128-140. 10.1016/0196-6553(88)90053-3, 2841893.
30. National Comprehensive Cancer Network (NCCN) NCCN Clinical Practice Guidelines in Oncology, Prevention and Treatment of Cancer- Related Infections 2007, National Comprehensive Cancer Network (NCCN).
31. Harrison LB, Chadhaa M, Hill RJ, Hu K, Shashaa D. Impact of tumor hypoxia and anemia on radiontherapy outcomes. Journal of Oncologist 2002, 7(6):492-508.
32. Rautemaa R, Rusanen P, Richardson M, Meurma JH. Optimal sampling site for mucosal candidosis in oral cancer patients is the labial sulcus. J Med Microbiol 2006, 55:1447-1451. 10.1099/jmm.0.46615-0, 17005796.
33. Shimeld LA. Essential of Diagnostic Microbiology 1998, USA: International Thomas Publishing Company.
34. Hawkey P, Law D. Medical Bacteriology 2004, New York: Oxford University Press.
35. Ryan KJ. Normal Microbial flora. Medical Microbiology 2004, USA: McGraw Hill, Sherris JC, Ryan KJ, Ray GC, Fourthth edition.
36. Pawar VB, Dutta D. From Diagnostic Bacteriology. A procedure manual for routine diagnostic test. Volume 2 2006, 554-626. New Delhi: Tata MacGrew -Hill Publishing Company Limited, Mukherjee KL.
37. Hughes WT, Armstrong D, Bodey GP. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002, 34:730-751. 10.1086/339215, 11850858.
38. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995, 26:1526-1530.
39. Martino P, Girmenia C, Micozzi A. Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients. Eur J Clin Microbiol Infect Dis 1994, 13:797-804. 10.1007/BF02111339, 7889948.
40. Amar S, Vishinu C, Emily W, et al. Prospective study of candida species in patients at a comprehensive cancer center. Antimicrob Agents Chemother 2001, 45:2129-2133. 10.1128/AAC.45.7.2129-2133.2001, 90613, 11408236.
41. Senler FC, Cakmakci S, Akan OA, Demirkazik A, Akbulut HF. Characteristics of Oropharyngeal Candida and Bacterial Colonization in Cancer Patients. International Journal of Hematology and Oncology 2012, 22:1-7.
42. Rolston KVI, Tarrand JJ. Pseudomonas aeruginosa-still a frequent pathogen in patients with cancer: 11-year experience at a comprehensive cancer center. Clin Infect Dis 1999, 29:463-464. 10.1086/520247, 10476774.
43. Jagarlamudi R, Kumar L, Kapil A. Infections in acute leukemia: an analysis of 240 febrile episodes. Med Oncol 2000, 17(2):111-116. 10.1007/BF02796205, 10871816.
44. Wisplinghoff H, Seifert H, Wenzel RP, Edmond B. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003, 36:1103-1110. 10.1086/374339, 12715303.
45. Raad I, Hachem R, Hanna H, Bahna P, Chatzinikolaou I, Fang X, Jiang Y, Chemaly RF, Rolston K. Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters. Eur J Clin Microbiol Infect Dis 2007, 26:549-556. 10.1007/s10096-007-0320-6, 17582536.
46. Babay HA. Bacterial isolates from fatal cases of bloodstream infection at a university hospital in central, Saudi Arabia. Saudi Med J 2007, 28(2):231-235.
47. Kanafani ZA, Dakdouki GK, El-Chammas KI, Eid S, Araj GF, Kanj SS. Bloodstream infections in febrile neutropenic patients at a tertiary care center in Lebanon: a view of the past decade. Int J Infect Dis 2007, 11:450-453. 10.1016/j.ijid.2006.12.008, 17337226.
48. Baskaran ND, Gan GG, Adeeba K, Sam IC. Bacteraemia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia. Int J Infect Dis 2007, 6:513-517.
49. Luzzaro F, Vigano EF, Fossati D. Prevalence and drug susceptibilities of pathogens causing bloodstream infection in northern Italy: a two year study in 16 hospitals. Eur J Clin Microbial Infect Dis 2002, 21:849.
50. Raje NS, Rao SR, Iyer RS, Kelkar RS, Pai SK, Nair CN, Kurkure PA, Magrath IT, Advani SH. Infection analysis in acute lymphoblastic leukemia: a report of 499 consecutive episodes in India. Pediatr Hematol Oncol 1994, 11:271-280. 10.3109/08880019409141670, 8060811.
51. Karim M, Khan W, Farooqi B, Malik I. Bacterial isolates in neutropenic febrile patients. J Pak Med Assoc 1991, 41:35-37.
52. Saghir S, Faiz M, Saleem M, Younus A, Aziz H. Characterization and anti - microbial susceptibility of gram - negative bacteria isolated from bloodstream infections of cancer patients on Chemotherapy in Pakistan. Indian J of Medical Microbiology 2009, 27(4):341-347.
53. Bakshi S, Padmanjali KS, Arya LS. Infections in childhood acute lymphoblastic leukemia: An analysis of 222 febrile neutropenic episodes. Pediatr Hematol Oncol 2008, 25(5):385-392. 10.1080/08880010802106564, 18569840.
54. Khan SA, Wingard JR. Infection and Mucosal Injury in Cancer Treatment. J Natl Cancer Inst Monogr 2001, 29:31-36.
55. Ei Kholy A, Baseem H, Hall GS. Antimicrobial resistance in Cairo, Egypt 1999-2000: A survey of five hospitals. J Antimicrob Chemother 2003, 51:625-630. 10.1093/jac/dkg101, 12615864.
56. Nickerson EK, Wuthiekanun V, Wongsuvan G, Limmathurosakul D, Srisamang P. Factors Predicting and Reducing Mortality in Patients with Invasive Staphylococcus aureus Disease in a Developing Country. PLoS One 2009, 4(8):1-8.
57. Nicolatou-Galitis O, Sotiropoulou-Lontou A, Velegraki A, Pissakas G, Kolitsi G, Kyprianou K, Kouloulias V, Papanikolaou I, Yiotakis I, Dardoufas K. Oral candidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection. Oral Oncol 2003, 39:397-401. 10.1016/S1368-8375(02)00144-6, 12676261.
58. Bagg J, Sweeney MP, Lewis MAO, Jackson MS, Coleman D, Al Mosaid A, Baxter W, McEndrick S, McHugh S. High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer. Palliative Medicibne 2003, 17:477-481.
59. Belazi M, Velegraki A, Koussidou-Eremondi T, Andreadis D, Hini S, Arsenis G, Eliopoulou C, Destouni E, Antoniades D. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment. Oral Microbiol Immunol 2004, 19(6):347-351. 10.1111/j.1399-302x.2004.00165.x, 15491459.
60. Davies AN, Brailsford SR, Beighton D. Oral candidosis in patients with advanced cancer. Oral Oncol 2006, 42:698-702. 10.1016/j.oraloncology.2005.11.010, 16527512.
61. Schelenz S, Abdallah S, Gray G, Stubbings H, Gow I, Baker P, Hunter PR. Epidemiology of oral yeast colonization and infection in patients with hematological malignancies, head neck and solid tumors. J Oral Pathol Med 2011, 40:83-89. 10.1111/j.1600-0714.2010.00937.x, 20923440.
62. Blijlevens NM, Donnelly JP, De Pauw BE. Mucosal barrier injury: Biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy-an overview. Bone Marrow Transplant 2000, 25:1269-1278. 10.1038/sj.bmt.1702447, 10871732.
63. Fu KK, Pajak TF, Trotti A. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000, 48:7-16. 10.1016/S0360-3016(00)00663-5, 10924966.
64. Spiellberger B, Powers JH, Brass EP, Miller LG, Edwards JE. Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 2004, 38:1279-1286. 10.1086/420937, 15127341.
65. Scully C, Sonis S, Diz PD. Oral mucositis. Oral Dis 2006, 12(3):229-241. 10.1111/j.1601-0825.2006.01258.x, 16700732.
66. Merlano M, Vitale V, Rosso R. Treatment of advance squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Eng J Med 1992, 327:1115-1121.
67. Brizel DM, Leopold KA, Fisher SR. A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1994, 28:213-220. 10.1016/0360-3016(94)90160-0, 8270444.